Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Access

Erosive arthritis

Georg Schett

Arthritis Research & Therapy 2007, 9(Suppl 1):S2 doi:10.1186/ar2166

Accesses  

  • Last 30 days: 182 accesses
  • Last 365 days: 1697 accesses
  • All time: 8970 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

Benoit Le Goff, Elise Soltner, Céline Charrier, Yves Maugars, Françoise Rédini, Dominique Heymann, Jean-Marie Berthelot Arthritis Research & Therapy 2009, 11:R185 (10 December 2009)

Review   Free Highly Accessed

Developments in the scientific understanding of rheumatoid arthritis

Jörg J Goronzy, Cornelia M Weyand Arthritis Research & Therapy 2009, 11:249 (14 October 2009)

This article is part of a collection on The Scientific Basis of...